Home Contact Sitemap

PedAM

Pediatric Disease Annotations & Medicines



   migraine with aura
  

Disease ID 661
Disease migraine with aura
Definition
A migraine disorder characterized by episodes that are preceded by focal neurological symptoms.
Synonym
aura migraine
aura migraines
auras migraines
classic migraine
classic migraines
classical migraine
migraine aura
migraine auras
migraine classical
migraine preceded or accompanied by transient focal neurological phenomena
migraine with aura (disorder)
migraine with aura [disease/finding]
migraine with auras
DOID
UMLS
C0154723
MeSH
SNOMED-CT
Comorbidity
UMLS | Disease | Sentences' Count(Total Sentences:19)
C0154723  |  migraine with aura  |  316
C0149931  |  migraine  |  285
C0011570  |  depression  |  5
C1735856  |  classic migraine  |  3
C0007222  |  cardiovascular disease  |  2
C0338480  |  migraine without aura  |  2
C0042373  |  vascular disease  |  2
C0027765  |  neurological disorders  |  1
C0020538  |  hypertension  |  1
C0155626  |  acute mi  |  1
C0042075  |  urological disorders  |  1
C0027765  |  neurological disorder  |  1
C0016522  |  patent foramen ovale  |  1
C0024623  |  gastric cancer  |  1
C0036341  |  schizophrenia  |  1
C0338480  |  common migraine  |  1
C0002986  |  fabry disease  |  1
C0085278  |  antiphospholipid syndrome  |  1
C0035258  |  restless legs syndrome  |  1
Curated Gene
Entrez_id | Symbol | Resource(Total Genes:8)
ATP1A2  |  477  |  GHR
SCN1A  |  6323  |  GHR
CACNA1A  |  773  |  GHR
PRRT2  |  112476  |  GHR
NEDD4L  |  23327  |  GWASCAT
TRPM8  |  79054  |  GWASCAT
VSTM4  |  196740  |  GWASCAT
ADARB2  |  105  |  GWASCAT
Inferring Gene
Entrez_id | Symbol | Resource(Total Genes:24)
1636  |  ACE  |  infer
477  |  ATP1A2  |  infer
773  |  CACNA1A  |  infer
777  |  CACNA1E  |  infer
54897  |  CASZ1  |  infer
1621  |  DBH  |  infer
1813  |  DRD2  |  infer
1909  |  EDNRA  |  infer
1910  |  EDNRB  |  infer
2099  |  ESR1  |  infer
356  |  FASLG  |  infer
2558  |  GABRA5  |  infer
3351  |  HTR1B  |  infer
3352  |  HTR1D  |  infer
3356  |  HTR2A  |  infer
3358  |  HTR2C  |  infer
3643  |  INSR  |  infer
3766  |  KCNJ10  |  infer
3765  |  KCNJ9  |  infer
4524  |  MTHFR  |  infer
4538  |  MT-ND4  |  infer
4846  |  NOS3  |  infer
6531  |  SLC6A3  |  infer
6532  |  SLC6A4  |  infer
Text Mined Gene
Entrez_id | Symbol | Score | Resource(Total Genes:141)
100506492  |  DSCAM-AS1  |  DISEASES
1815  |  DRD4  |  DISEASES
53405  |  CLIC5  |  DISEASES
2099  |  ESR1  |  DISEASES
10627  |  MYL12A  |  DISEASES
55512  |  SMPD3  |  DISEASES
6804  |  STX1A  |  DISEASES
4619  |  MYH1  |  DISEASES
116449  |  CLNK  |  DISEASES
24145  |  PANX1  |  DISEASES
41  |  ASIC1  |  DISEASES
103910  |  MYL12B  |  DISEASES
3218  |  HOXB8  |  DISEASES
5300  |  PIN1  |  DISEASES
8220  |  DGCR14  |  DISEASES
5589  |  PRKCSH  |  DISEASES
8864  |  PER2  |  DISEASES
10267  |  RAMP1  |  DISEASES
1401  |  CRP  |  DISEASES
10955  |  SERINC3  |  DISEASES
3357  |  HTR2B  |  DISEASES
51719  |  CAB39  |  DISEASES
4836  |  NMT1  |  DISEASES
1419  |  CRYGB  |  DISEASES
6532  |  SLC6A4  |  DISEASES
9914  |  ATP2C2  |  DISEASES
443  |  ASPA  |  DISEASES
5024  |  P2RX3  |  DISEASES
4854  |  NOTCH3  |  DISEASES
2892  |  GRIA3  |  DISEASES
4552  |  MTRR  |  DISEASES
64083  |  GOLPH3  |  DISEASES
1181  |  CLCN2  |  DISEASES
775  |  CACNA1C  |  DISEASES
6895  |  TARBP2  |  DISEASES
8620  |  NPFF  |  DISEASES
3705  |  ITPK1  |  DISEASES
6531  |  SLC6A3  |  DISEASES
63976  |  PRDM16  |  DISEASES
3782  |  KCNN3  |  DISEASES
25953  |  PNKD  |  DISEASES
3358  |  HTR2C  |  DISEASES
7564  |  ZNF16  |  DISEASES
288  |  ANK3  |  DISEASES
6326  |  SCN2A  |  DISEASES
23250  |  ATP11A  |  DISEASES
2890  |  GRIA1  |  DISEASES
4325  |  MMP16  |  DISEASES
54102  |  CLIC6  |  DISEASES
57369  |  GJD2  |  DISEASES
1636  |  ACE  |  DISEASES
8209  |  C21orf33  |  DISEASES
3060  |  HCRT  |  DISEASES
57465  |  TBC1D24  |  DISEASES
476  |  ATP1A1  |  DISEASES
5196  |  PF4  |  DISEASES
54859  |  ELP6  |  DISEASES
4846  |  NOS3  |  DISEASES
7001  |  PRDX2  |  DISEASES
1632  |  ECI1  |  DISEASES
51305  |  KCNK9  |  DISEASES
478  |  ATP1A3  |  DISEASES
9196  |  KCNAB3  |  DISEASES
6323  |  SCN1A  |  DISEASES
3643  |  INSR  |  DISEASES
3790  |  KCNS3  |  DISEASES
2353  |  FOS  |  DISEASES
435  |  ASL  |  DISEASES
2147  |  F2  |  DISEASES
3265  |  HRAS  |  DISEASES
54207  |  KCNK10  |  DISEASES
93107  |  KCNG4  |  DISEASES
4281  |  MID1  |  DISEASES
5062  |  PAK2  |  DISEASES
1909  |  EDNRA  |  DISEASES
783  |  CACNB2  |  DISEASES
6863  |  TAC1  |  DISEASES
10229  |  COQ7  |  DISEASES
79054  |  TRPM8  |  DISEASES
8204  |  NRIP1  |  DISEASES
56660  |  KCNK12  |  DISEASES
6331  |  SCN5A  |  DISEASES
221692  |  PHACTR1  |  DISEASES
57419  |  SLC24A3  |  DISEASES
338567  |  KCNK18  |  DISEASES
3363  |  HTR7  |  DISEASES
4128  |  MAOA  |  DISEASES
5828  |  PEX2  |  DISEASES
112476  |  PRRT2  |  DISEASES
8913  |  CACNA1G  |  DISEASES
8021  |  NUP214  |  DISEASES
773  |  CACNA1A  |  DISEASES
1284  |  COL4A2  |  DISEASES
477  |  ATP1A2  |  DISEASES
1312  |  COMT  |  DISEASES
916  |  CD3E  |  DISEASES
10781  |  ZNF266  |  DISEASES
1813  |  DRD2  |  DISEASES
23038  |  WDTC1  |  DISEASES
4548  |  MTR  |  DISEASES
3775  |  KCNK1  |  DISEASES
777  |  CACNA1E  |  DISEASES
844  |  CASQ1  |  DISEASES
480  |  ATP1A4  |  DISEASES
3765  |  KCNJ9  |  DISEASES
3766  |  KCNJ10  |  DISEASES
23376  |  UFL1  |  DISEASES
10100  |  TSPAN2  |  DISEASES
3351  |  HTR1B  |  DISEASES
3062  |  HCRTR2  |  DISEASES
6015  |  RING1  |  DISEASES
4855  |  NOTCH4  |  DISEASES
4524  |  MTHFR  |  DISEASES
8573  |  CASK  |  DISEASES
57380  |  MRS2  |  DISEASES
170302  |  ARX  |  DISEASES
1906  |  EDN1  |  DISEASES
114899  |  C1QTNF3  |  DISEASES
1814  |  DRD3  |  DISEASES
1621  |  DBH  |  DISEASES
145270  |  PRIMA1  |  DISEASES
50801  |  KCNK4  |  DISEASES
4784  |  NFIX  |  DISEASES
23365  |  ARHGEF12  |  DISEASES
594857  |  NPS  |  DISEASES
7442  |  TRPV1  |  DISEASES
6335  |  SCN9A  |  DISEASES
11277  |  TREX1  |  DISEASES
3776  |  KCNK2  |  DISEASES
57506  |  MAVS  |  DISEASES
4049  |  LTA  |  DISEASES
2900  |  GRIK4  |  DISEASES
9312  |  KCNB2  |  DISEASES
123041  |  SLC24A4  |  DISEASES
785  |  CACNB4  |  DISEASES
10198  |  MPHOSPH9  |  DISEASES
4522  |  MTHFD1  |  DISEASES
162514  |  TRPV3  |  DISEASES
102723508  |  KANTR  |  DISEASES
104564225  |  MHRT  |  DISEASES
4553  |  MT-TA  |  DISEASES
Locus(Waiting for update.)
Disease ID 661
Disease migraine with aura
Integrated Phenotype(Waiting for update.)
Text Mined Phenotype
HPO | Name | Sentences' Count(Total Phenotypes:16)
HP:0002077  |  Migraine with aura  |  316
HP:0002076  |  Migraine headaches  |  285
HP:0002315  |  Headaches  |  6
HP:0001297  |  Cerebral vascular events  |  6
HP:0000716  |  Depression  |  5
HP:0002140  |  Ischemic stroke  |  2
HP:0002083  |  Migraine without aura  |  2
HP:0012531  |  Pain  |  2
HP:0002647  |  Aortic dissection  |  1
HP:0001250  |  Seizures  |  1
HP:0000822  |  Hypertension  |  1
HP:0100753  |  Schizophrenia  |  1
HP:0012126  |  Gastric cancer  |  1
HP:0001655  |  Patent foramen ovale  |  1
HP:0001694  |  Right-to-left shunt  |  1
HP:0002321  |  Vertigo  |  1
Disease ID 661
Disease migraine with aura
Manually Symptom(Waiting for update.)
Text Mined Symptom
UMLS | Name | Sentences' Count(Total Symptoms:4)
C0018681  |  headache  |  5
C0235169  |  excitability  |  2
C0016522  |  patent foramen ovale  |  1
C0036572  |  seizures  |  1
Manually Genotype(Total Text Mining Genotypes:0)
(Waiting for update.)
All Snps(Total Genotypes:53)
snpId pubmedId geneId geneSymbol diseaseId sourceId sentence score Year geneSymbol_dbSNP CHROMOSOME POS REF ALT
rs104894561236360921453CSNK1Dumls:C0154723BeFreeCKIδ-T44A mice also exhibited a reduced threshold for cortical spreading depression (believed to be the physiological analog of migraine aura) and greater arterial dilation during cortical spreading depression.0.0002714422014CSNK1D1782265743TC
rs11172113248522924035LRP1umls:C0154723BeFreeFive loci met stringent significance for association with migraine, among which four were selective for sub-classified migraine, including rs11172113 (LRP1) for MO.0.0002714422014LRP11257133500TC
rs1227336324708359627BDNFumls:C0154723BeFreeFive SNPs in the BDNF locus (rs1519480, rs6265, rs712507, rs2049046, and rs12273363) were genotyped initially in a cohort of 277 migraine cases, including 172 diagnosed with migraine with aura (MA) and 105 with migraine without aura (MO), and 277 age- and sex-matched controls.0.0002714422014BDNF1127723312TC
rs124540232379302523327NEDD4Lumls:C0154723GWASCATGenome-wide meta-analysis identifies new susceptibility loci for migraine.0.122013NEDD4L1858342372CT
rs151948024708359627BDNFumls:C0154723BeFreeFive SNPs in the BDNF locus (rs1519480, rs6265, rs712507, rs2049046, and rs12273363) were genotyped initially in a cohort of 277 migraine cases, including 172 diagnosed with migraine with aura (MA) and 105 with migraine without aura (MO), and 277 age- and sex-matched controls.0.0002714422014BDNF-AS1127654165CT
rs179986419559392342977NANOS3umls:C0154723BeFreeAmong active migraine with aura, the odds ratios (95% confidence intervals) were 1.35 (1.0 to 1.81) for TNF rs1800750, 1.13 (1.02 to 1.26) for TNF rs1800629, and 1.22 (1.07 to 1.40) for CCR2 rs1799864; among active migraine without aura, 0.9 (0.84 to 0.97) for TGFB1 rs1800469, 1.13 (1.01 to 1.27) for NOS3 rs3918226, and 1.12 (1.02 to 1.24) for IL9 rs2069885.0.0002714422009CCR2346357717GA
rs1799864195593927040TGFB1umls:C0154723BeFreeAmong active migraine with aura, the odds ratios (95% confidence intervals) were 1.35 (1.0 to 1.81) for TNF rs1800750, 1.13 (1.02 to 1.26) for TNF rs1800629, and 1.22 (1.07 to 1.40) for CCR2 rs1799864; among active migraine without aura, 0.9 (0.84 to 0.97) for TGFB1 rs1800469, 1.13 (1.01 to 1.27) for NOS3 rs3918226, and 1.12 (1.02 to 1.24) for IL9 rs2069885.0.0002714422009CCR2346357717GA
rs1799864195593923578IL9umls:C0154723BeFreeAmong active migraine with aura, the odds ratios (95% confidence intervals) were 1.35 (1.0 to 1.81) for TNF rs1800750, 1.13 (1.02 to 1.26) for TNF rs1800629, and 1.22 (1.07 to 1.40) for CCR2 rs1799864; among active migraine without aura, 0.9 (0.84 to 0.97) for TGFB1 rs1800469, 1.13 (1.01 to 1.27) for NOS3 rs3918226, and 1.12 (1.02 to 1.24) for IL9 rs2069885.0.0002714422009CCR2346357717GA
rs1799864195593927124TNFumls:C0154723BeFreeAmong active migraine with aura, the odds ratios (95% confidence intervals) were 1.35 (1.0 to 1.81) for TNF rs1800750, 1.13 (1.02 to 1.26) for TNF rs1800629, and 1.22 (1.07 to 1.40) for CCR2 rs1799864; among active migraine without aura, 0.9 (0.84 to 0.97) for TGFB1 rs1800469, 1.13 (1.01 to 1.27) for NOS3 rs3918226, and 1.12 (1.02 to 1.24) for IL9 rs2069885.0.0005428842009CCR2346357717GA
rs179986419559392729230CCR2umls:C0154723BeFreeAmong active migraine with aura, the odds ratios (95% confidence intervals) were 1.35 (1.0 to 1.81) for TNF rs1800750, 1.13 (1.02 to 1.26) for TNF rs1800629, and 1.22 (1.07 to 1.40) for CCR2 rs1799864; among active migraine without aura, 0.9 (0.84 to 0.97) for TGFB1 rs1800469, 1.13 (1.01 to 1.27) for NOS3 rs3918226, and 1.12 (1.02 to 1.24) for IL9 rs2069885.0.0002714422009CCR2346357717GA
rs1799971227525684988OPRM1umls:C0154723BeFreeThe human μ-opioid receptor gene polymorphism (A118G) is associated with head pain severity in a clinical cohort of female migraine with aura patients.0.0002714422012OPRM16154039662AG
rs1799983171159914846NOS3umls:C0154723BeFreeEndothelial nitric oxide synthase (Glu298Asp) polymorphism is an independent risk factor for migraine with aura.0.0026384742006NOS37150999023TG
rs1800469195593923578IL9umls:C0154723BeFreeAmong active migraine with aura, the odds ratios (95% confidence intervals) were 1.35 (1.0 to 1.81) for TNF rs1800750, 1.13 (1.02 to 1.26) for TNF rs1800629, and 1.22 (1.07 to 1.40) for CCR2 rs1799864; among active migraine without aura, 0.9 (0.84 to 0.97) for TGFB1 rs1800469, 1.13 (1.01 to 1.27) for NOS3 rs3918226, and 1.12 (1.02 to 1.24) for IL9 rs2069885.0.0002714422009TGFB1;B9D21941354391AG
rs1800469195593927124TNFumls:C0154723BeFreeAmong active migraine with aura, the odds ratios (95% confidence intervals) were 1.35 (1.0 to 1.81) for TNF rs1800750, 1.13 (1.02 to 1.26) for TNF rs1800629, and 1.22 (1.07 to 1.40) for CCR2 rs1799864; among active migraine without aura, 0.9 (0.84 to 0.97) for TGFB1 rs1800469, 1.13 (1.01 to 1.27) for NOS3 rs3918226, and 1.12 (1.02 to 1.24) for IL9 rs2069885.0.0005428842009TGFB1;B9D21941354391AG
rs1800469195593927040TGFB1umls:C0154723BeFreeAmong active migraine with aura, the odds ratios (95% confidence intervals) were 1.35 (1.0 to 1.81) for TNF rs1800750, 1.13 (1.02 to 1.26) for TNF rs1800629, and 1.22 (1.07 to 1.40) for CCR2 rs1799864; among active migraine without aura, 0.9 (0.84 to 0.97) for TGFB1 rs1800469, 1.13 (1.01 to 1.27) for NOS3 rs3918226, and 1.12 (1.02 to 1.24) for IL9 rs2069885.0.0002714422009TGFB1;B9D21941354391AG
rs180046919559392342977NANOS3umls:C0154723BeFreeAmong active migraine with aura, the odds ratios (95% confidence intervals) were 1.35 (1.0 to 1.81) for TNF rs1800750, 1.13 (1.02 to 1.26) for TNF rs1800629, and 1.22 (1.07 to 1.40) for CCR2 rs1799864; among active migraine without aura, 0.9 (0.84 to 0.97) for TGFB1 rs1800469, 1.13 (1.01 to 1.27) for NOS3 rs3918226, and 1.12 (1.02 to 1.24) for IL9 rs2069885.0.0002714422009TGFB1;B9D21941354391AG
rs180046919559392729230CCR2umls:C0154723BeFreeAmong active migraine with aura, the odds ratios (95% confidence intervals) were 1.35 (1.0 to 1.81) for TNF rs1800750, 1.13 (1.02 to 1.26) for TNF rs1800629, and 1.22 (1.07 to 1.40) for CCR2 rs1799864; among active migraine without aura, 0.9 (0.84 to 0.97) for TGFB1 rs1800469, 1.13 (1.01 to 1.27) for NOS3 rs3918226, and 1.12 (1.02 to 1.24) for IL9 rs2069885.0.0002714422009TGFB1;B9D21941354391AG
rs1800629195593927124TNFumls:C0154723BeFreeAmong active migraine with aura, the odds ratios (95% confidence intervals) were 1.35 (1.0 to 1.81) for TNF rs1800750, 1.13 (1.02 to 1.26) for TNF rs1800629, and 1.22 (1.07 to 1.40) for CCR2 rs1799864; among active migraine without aura, 0.9 (0.84 to 0.97) for TGFB1 rs1800469, 1.13 (1.01 to 1.27) for NOS3 rs3918226, and 1.12 (1.02 to 1.24) for IL9 rs2069885.0.0005428842009TNF631575254GA
rs1800629195593923578IL9umls:C0154723BeFreeAmong active migraine with aura, the odds ratios (95% confidence intervals) were 1.35 (1.0 to 1.81) for TNF rs1800750, 1.13 (1.02 to 1.26) for TNF rs1800629, and 1.22 (1.07 to 1.40) for CCR2 rs1799864; among active migraine without aura, 0.9 (0.84 to 0.97) for TGFB1 rs1800469, 1.13 (1.01 to 1.27) for NOS3 rs3918226, and 1.12 (1.02 to 1.24) for IL9 rs2069885.0.0002714422009TNF631575254GA
rs180062919559392729230CCR2umls:C0154723BeFreeAmong active migraine with aura, the odds ratios (95% confidence intervals) were 1.35 (1.0 to 1.81) for TNF rs1800750, 1.13 (1.02 to 1.26) for TNF rs1800629, and 1.22 (1.07 to 1.40) for CCR2 rs1799864; among active migraine without aura, 0.9 (0.84 to 0.97) for TGFB1 rs1800469, 1.13 (1.01 to 1.27) for NOS3 rs3918226, and 1.12 (1.02 to 1.24) for IL9 rs2069885.0.0002714422009TNF631575254GA
rs180062919559392342977NANOS3umls:C0154723BeFreeAmong active migraine with aura, the odds ratios (95% confidence intervals) were 1.35 (1.0 to 1.81) for TNF rs1800750, 1.13 (1.02 to 1.26) for TNF rs1800629, and 1.22 (1.07 to 1.40) for CCR2 rs1799864; among active migraine without aura, 0.9 (0.84 to 0.97) for TGFB1 rs1800469, 1.13 (1.01 to 1.27) for NOS3 rs3918226, and 1.12 (1.02 to 1.24) for IL9 rs2069885.0.0002714422009TNF631575254GA
rs1800629195593927040TGFB1umls:C0154723BeFreeAmong active migraine with aura, the odds ratios (95% confidence intervals) were 1.35 (1.0 to 1.81) for TNF rs1800750, 1.13 (1.02 to 1.26) for TNF rs1800629, and 1.22 (1.07 to 1.40) for CCR2 rs1799864; among active migraine without aura, 0.9 (0.84 to 0.97) for TGFB1 rs1800469, 1.13 (1.01 to 1.27) for NOS3 rs3918226, and 1.12 (1.02 to 1.24) for IL9 rs2069885.0.0002714422009TNF631575254GA
rs1800750195593927040TGFB1umls:C0154723BeFreeAmong active migraine with aura, the odds ratios (95% confidence intervals) were 1.35 (1.0 to 1.81) for TNF rs1800750, 1.13 (1.02 to 1.26) for TNF rs1800629, and 1.22 (1.07 to 1.40) for CCR2 rs1799864; among active migraine without aura, 0.9 (0.84 to 0.97) for TGFB1 rs1800469, 1.13 (1.01 to 1.27) for NOS3 rs3918226, and 1.12 (1.02 to 1.24) for IL9 rs2069885.0.0002714422009TNF631575186GA
rs180075019559392729230CCR2umls:C0154723BeFreeAmong active migraine with aura, the odds ratios (95% confidence intervals) were 1.35 (1.0 to 1.81) for TNF rs1800750, 1.13 (1.02 to 1.26) for TNF rs1800629, and 1.22 (1.07 to 1.40) for CCR2 rs1799864; among active migraine without aura, 0.9 (0.84 to 0.97) for TGFB1 rs1800469, 1.13 (1.01 to 1.27) for NOS3 rs3918226, and 1.12 (1.02 to 1.24) for IL9 rs2069885.0.0002714422009TNF631575186GA
rs1800750195593927124TNFumls:C0154723BeFreeAmong active migraine with aura, the odds ratios (95% confidence intervals) were 1.35 (1.0 to 1.81) for TNF rs1800750, 1.13 (1.02 to 1.26) for TNF rs1800629, and 1.22 (1.07 to 1.40) for CCR2 rs1799864; among active migraine without aura, 0.9 (0.84 to 0.97) for TGFB1 rs1800469, 1.13 (1.01 to 1.27) for NOS3 rs3918226, and 1.12 (1.02 to 1.24) for IL9 rs2069885.0.0005428842009TNF631575186GA
rs180075019559392342977NANOS3umls:C0154723BeFreeAmong active migraine with aura, the odds ratios (95% confidence intervals) were 1.35 (1.0 to 1.81) for TNF rs1800750, 1.13 (1.02 to 1.26) for TNF rs1800629, and 1.22 (1.07 to 1.40) for CCR2 rs1799864; among active migraine without aura, 0.9 (0.84 to 0.97) for TGFB1 rs1800469, 1.13 (1.01 to 1.27) for NOS3 rs3918226, and 1.12 (1.02 to 1.24) for IL9 rs2069885.0.0002714422009TNF631575186GA
rs1800750195593923578IL9umls:C0154723BeFreeAmong active migraine with aura, the odds ratios (95% confidence intervals) were 1.35 (1.0 to 1.81) for TNF rs1800750, 1.13 (1.02 to 1.26) for TNF rs1800629, and 1.22 (1.07 to 1.40) for CCR2 rs1799864; among active migraine without aura, 0.9 (0.84 to 0.97) for TGFB1 rs1800469, 1.13 (1.01 to 1.27) for NOS3 rs3918226, and 1.12 (1.02 to 1.24) for IL9 rs2069885.0.0002714422009TNF631575186GA
rs204904624708359627BDNFumls:C0154723BeFreeFive SNPs in the BDNF locus (rs1519480, rs6265, rs712507, rs2049046, and rs12273363) were genotyped initially in a cohort of 277 migraine cases, including 172 diagnosed with migraine with aura (MA) and 105 with migraine without aura (MO), and 277 age- and sex-matched controls.0.0002714422014BDNF1127702228TA
rs2069885195593927040TGFB1umls:C0154723BeFreeAmong active migraine with aura, the odds ratios (95% confidence intervals) were 1.35 (1.0 to 1.81) for TNF rs1800750, 1.13 (1.02 to 1.26) for TNF rs1800629, and 1.22 (1.07 to 1.40) for CCR2 rs1799864; among active migraine without aura, 0.9 (0.84 to 0.97) for TGFB1 rs1800469, 1.13 (1.01 to 1.27) for NOS3 rs3918226, and 1.12 (1.02 to 1.24) for IL9 rs2069885.0.0002714422009IL95135892476GA
rs206988519559392342977NANOS3umls:C0154723BeFreeAmong active migraine with aura, the odds ratios (95% confidence intervals) were 1.35 (1.0 to 1.81) for TNF rs1800750, 1.13 (1.02 to 1.26) for TNF rs1800629, and 1.22 (1.07 to 1.40) for CCR2 rs1799864; among active migraine without aura, 0.9 (0.84 to 0.97) for TGFB1 rs1800469, 1.13 (1.01 to 1.27) for NOS3 rs3918226, and 1.12 (1.02 to 1.24) for IL9 rs2069885.0.0002714422009IL95135892476GA
rs2069885195593927124TNFumls:C0154723BeFreeAmong active migraine with aura, the odds ratios (95% confidence intervals) were 1.35 (1.0 to 1.81) for TNF rs1800750, 1.13 (1.02 to 1.26) for TNF rs1800629, and 1.22 (1.07 to 1.40) for CCR2 rs1799864; among active migraine without aura, 0.9 (0.84 to 0.97) for TGFB1 rs1800469, 1.13 (1.01 to 1.27) for NOS3 rs3918226, and 1.12 (1.02 to 1.24) for IL9 rs2069885.0.0005428842009IL95135892476GA
rs206988519559392729230CCR2umls:C0154723BeFreeAmong active migraine with aura, the odds ratios (95% confidence intervals) were 1.35 (1.0 to 1.81) for TNF rs1800750, 1.13 (1.02 to 1.26) for TNF rs1800629, and 1.22 (1.07 to 1.40) for CCR2 rs1799864; among active migraine without aura, 0.9 (0.84 to 0.97) for TGFB1 rs1800469, 1.13 (1.01 to 1.27) for NOS3 rs3918226, and 1.12 (1.02 to 1.24) for IL9 rs2069885.0.0002714422009IL95135892476GA
rs2069885195593923578IL9umls:C0154723BeFreeAmong active migraine with aura, the odds ratios (95% confidence intervals) were 1.35 (1.0 to 1.81) for TNF rs1800750, 1.13 (1.02 to 1.26) for TNF rs1800629, and 1.22 (1.07 to 1.40) for CCR2 rs1799864; among active migraine without aura, 0.9 (0.84 to 0.97) for TGFB1 rs1800469, 1.13 (1.01 to 1.27) for NOS3 rs3918226, and 1.12 (1.02 to 1.24) for IL9 rs2069885.0.0002714422009IL95135892476GA
rs213792023793025196740VSTM4umls:C0154723GWASCATGenome-wide meta-analysis identifies new susceptibility loci for migraine.0.122013VSTM41049021593TA
rs222741221624177442TRPV1umls:C0154723BeFreeIn the replication sample, nominal association was confirmed for TRPV3 rs7217270 in MA and TRPV1 rs222741 in the overall migraine group.0.0002714422012TRPV1173605586GA
rs22274122162417162514TRPV3umls:C0154723BeFreeIn the replication sample, nominal association was confirmed for TRPV3 rs7217270 in MA and TRPV1 rs222741 in the overall migraine group.0.0002714422012TRPV1173605586GA
rs2234693225119672099ESR1umls:C0154723BeFreeOut of four ESR1 polymorphisms, only rs2234693 variant allele was significantly associated in migraine with aura.0.0031813582012ESR16151842200TC
rs282065123793025105ADARB2umls:C0154723GWASCATGenome-wide meta-analysis identifies new susceptibility loci for migraine.0.122013ADARB2101429570CA
rs386596107252956436648SOD2umls:C0154723BeFreeIs SOD2 Ala16Val polymorphism associated with migraine with aura phenotype?0.0002714422015NANANANANA
rs3918226195593927124TNFumls:C0154723BeFreeAmong active migraine with aura, the odds ratios (95% confidence intervals) were 1.35 (1.0 to 1.81) for TNF rs1800750, 1.13 (1.02 to 1.26) for TNF rs1800629, and 1.22 (1.07 to 1.40) for CCR2 rs1799864; among active migraine without aura, 0.9 (0.84 to 0.97) for TGFB1 rs1800469, 1.13 (1.01 to 1.27) for NOS3 rs3918226, and 1.12 (1.02 to 1.24) for IL9 rs2069885.0.0005428842009NOS37150993088CT
rs3918226195593923578IL9umls:C0154723BeFreeAmong active migraine with aura, the odds ratios (95% confidence intervals) were 1.35 (1.0 to 1.81) for TNF rs1800750, 1.13 (1.02 to 1.26) for TNF rs1800629, and 1.22 (1.07 to 1.40) for CCR2 rs1799864; among active migraine without aura, 0.9 (0.84 to 0.97) for TGFB1 rs1800469, 1.13 (1.01 to 1.27) for NOS3 rs3918226, and 1.12 (1.02 to 1.24) for IL9 rs2069885.0.0002714422009NOS37150993088CT
rs3918226195593927040TGFB1umls:C0154723BeFreeAmong active migraine with aura, the odds ratios (95% confidence intervals) were 1.35 (1.0 to 1.81) for TNF rs1800750, 1.13 (1.02 to 1.26) for TNF rs1800629, and 1.22 (1.07 to 1.40) for CCR2 rs1799864; among active migraine without aura, 0.9 (0.84 to 0.97) for TGFB1 rs1800469, 1.13 (1.01 to 1.27) for NOS3 rs3918226, and 1.12 (1.02 to 1.24) for IL9 rs2069885.0.0002714422009NOS37150993088CT
rs391822619559392729230CCR2umls:C0154723BeFreeAmong active migraine with aura, the odds ratios (95% confidence intervals) were 1.35 (1.0 to 1.81) for TNF rs1800750, 1.13 (1.02 to 1.26) for TNF rs1800629, and 1.22 (1.07 to 1.40) for CCR2 rs1799864; among active migraine without aura, 0.9 (0.84 to 0.97) for TGFB1 rs1800469, 1.13 (1.01 to 1.27) for NOS3 rs3918226, and 1.12 (1.02 to 1.24) for IL9 rs2069885.0.0002714422009NOS37150993088CT
rs391822619559392342977NANOS3umls:C0154723BeFreeAmong active migraine with aura, the odds ratios (95% confidence intervals) were 1.35 (1.0 to 1.81) for TNF rs1800750, 1.13 (1.02 to 1.26) for TNF rs1800629, and 1.22 (1.07 to 1.40) for CCR2 rs1799864; among active migraine without aura, 0.9 (0.84 to 0.97) for TGFB1 rs1800469, 1.13 (1.01 to 1.27) for NOS3 rs3918226, and 1.12 (1.02 to 1.24) for IL9 rs2069885.0.0002714422009NOS37150993088CT
rs4127688620080591773CACNA1Aumls:C0154723BeFreeWe now report on a mutation identified in the first intracellular loop of CACNA1A (alpha(1A(A454T))) that does not cause FHM but is associated with the absence of sensorimotor symptoms in a migraine with aura pedigree.0.0164358592010CACNA1A1913317310CT
rs4880252956436648SOD2umls:C0154723BeFreeIs SOD2 Ala16Val polymorphism associated with migraine with aura phenotype?0.0002714422015SOD26159692840AG
rs626524708359627BDNFumls:C0154723BeFreeFive SNPs in the BDNF locus (rs1519480, rs6265, rs712507, rs2049046, and rs12273363) were genotyped initially in a cohort of 277 migraine cases, including 172 diagnosed with migraine with aura (MA) and 105 with migraine without aura (MO), and 277 age- and sex-matched controls.0.0002714422014BDNF;BDNF-AS1127658369CT
rs6318179019213358HTR2Cumls:C0154723BeFreeOur study did not confirm the HTR2C Cys23Ser polymorphism as a risk factor for migraine and MA.0.0086300582007HTR2C;LOC105373313X114731326CG
rs6318151474643358HTR2Cumls:C0154723BeFreeThe present study provides that 5HTR2c Cys23Ser polymorphism may be associated with MWA in Japanese population.0.0086300582004HTR2C;LOC105373313X114731326CG
rs67417512379302579054TRPM8umls:C0154723GWASCATGenome-wide meta-analysis identifies new susceptibility loci for migraine.0.122013TRPM82233919016GA
rs71250724708359627BDNFumls:C0154723BeFreeFive SNPs in the BDNF locus (rs1519480, rs6265, rs712507, rs2049046, and rs12273363) were genotyped initially in a cohort of 277 migraine cases, including 172 diagnosed with migraine with aura (MA) and 105 with migraine without aura (MO), and 277 age- and sex-matched controls.0.0002714422014PHLDB23111936542TC
rs7217270221624177442TRPV1umls:C0154723BeFreeIn the replication sample, nominal association was confirmed for TRPV3 rs7217270 in MA and TRPV1 rs222741 in the overall migraine group.0.0002714422012TRPV3173518181AG
rs721727022162417162514TRPV3umls:C0154723BeFreeIn the replication sample, nominal association was confirmed for TRPV3 rs7217270 in MA and TRPV1 rs222741 in the overall migraine group.0.0002714422012TRPV3173518181AG
GWASdb Annotation(Total Genotypes:0)
(Waiting for update.)
GWASdb Snp Trait(Total Genotypes:41)
CHR POS SNPID REF ALT ORI_SNPID PMID P_VALUE P_VALUE_TEXT OR/BETA CI95_TEXT GWAS_INITIAL_SAMPLE_SIZE SUB_POPULATION SUPER_POPULATION GWAS_TRAIT HPO_ID HPO_TERM DO_ID DO_TERM MESH_ID MESH_TERM EFO_ID EFO_TERM DOLITE_TERM RISK_ALLELE PUBLICATION_TYPE AA GENE_SYMBOL TYPE REFGENE
13083712rs2651899TCrs2651899237930252.54E-04NANANA5,118 European ancestry cases; 74,239 European ancestry controlsEuropean(79357)ALL(79357)EUR(79357)ALL(79357)Migraine with auraHPOID:0002077Migraine with auraDOID:10024migraine with auraNANANANAMigraineNAMeta-AnalysisGPRDM16
14183006rs10915437AGrs10915437237930251.56E-04NA1.11[0.86-0.95]5,118 European ancestry cases; 74,239 European ancestry controlsEuropean(79357)ALL(79357)EUR(79357)ALL(79357)Migraine with auraHPOID:0002077Migraine with auraDOID:10024migraine with auraNANANANAMigraineNAMeta-AnalysisANA
15661009rs7528859TArs7528859237930255.00E-06NA1.12[1.07-1.18]5,118 European ancestry cases; 74,239 European ancestry controlsEuropean(79357)ALL(79357)EUR(79357)ALL(79357)Migraine with auraHPOID:0002077Migraine with auraDOID:10024migraine with auraNANANANAMigrainers7528859-AMeta-AnalysisANA
1115677946rs12134493CArs12134493237930256.19E-04NA1.13[1.05-1.21]5,118 European ancestry cases; 74,239 European ancestry controlsEuropean(79357)ALL(79357)EUR(79357)ALL(79357)Migraine with auraHPOID:0002077Migraine with auraDOID:10024migraine with auraNANANANAMigrainers12134493-AMeta-AnalysisCNA
1246223120rs6693295CTrs6693295237930256.00E-06NA1.14[1.08-1.21]5,118 European ancestry cases; 74,239 European ancestry controlsEuropean(79357)ALL(79357)EUR(79357)ALL(79357)Migraine with auraHPOID:0002077Migraine with auraDOID:10024migraine with auraNANANANAMigrainers6693295-TMeta-AnalysisTSMYD3
2234825093rs10166942TCrs10166942237930251.69E-06NANANA5,118 European ancestry cases; 74,239 European ancestry controlsEuropean(79357)ALL(79357)EUR(79357)ALL(79357)Migraine with auraHPOID:0002077Migraine with auraDOID:10024migraine with auraNANANANAMigraineNAMeta-AnalysisCNA
2234827661rs6741751GArs6741751237930251.00E-07NA1.23[1.14-1.33]5,118 European ancestry cases; 74,239 European ancestry controlsEuropean(79357)ALL(79357)EUR(79357)ALL(79357)Migraine with auraHPOID:0002077Migraine with auraDOID:10024migraine with auraNANANANAMigraineNAMeta-AnalysisGTRPM8
371464335rs13063872GArs13063872237930253.62E-05NA1.22[0.75-0.90]5,118 European ancestry cases; 74,239 European ancestry controlsEuropean(79357)ALL(79357)EUR(79357)ALL(79357)Migraine with auraHPOID:0002077Migraine with auraDOID:10024migraine with auraNANANANAMigraineNAMeta-AnalysisGFOXP1
441639516rs4345220AGrs4345220237930252.00E-06NA1.15[1.09-1.20]5,118 European ancestry cases; 74,239 European ancestry controlsEuropean(79357)ALL(79357)EUR(79357)ALL(79357)Migraine with auraHPOID:0002077Migraine with auraDOID:10024migraine with auraNANANANAMigraineNAMeta-AnalysisGLIMCH1
5127716567rs17608902CArs17608902237930259.00E-06NA1.19[1.10-1.28]5,118 European ancestry cases; 74,239 European ancestry controlsEuropean(79357)ALL(79357)EUR(79357)ALL(79357)Migraine with auraHPOID:0002077Migraine with auraDOID:10024migraine with auraNANANANAMigrainers17608902-AMeta-AnalysisCFBN2
5142899801rs12153243ATrs12153243237930253.66E-04NA1.09[1.04-1.14]5,118 European ancestry cases; 74,239 European ancestry controlsEuropean(79357)ALL(79357)EUR(79357)ALL(79357)Migraine with auraHPOID:0002077Migraine with auraDOID:10024migraine with auraNANANANAMigrainers12153243-TMeta-AnalysisANA
6131446791rs602848CGrs602848237930255.00E-06NA1.16[1.09-1.24]5,118 European ancestry cases; 74,239 European ancestry controlsEuropean(79357)ALL(79357)EUR(79357)ALL(79357)Migraine with auraHPOID:0002077Migraine with auraDOID:10024migraine with auraNANANANAMigrainers602848-CMeta-AnalysisGNA
715758000rs2159222ATrs2159222237930258.00E-06NA1.16[1.09-1.23]5,118 European ancestry cases; 74,239 European ancestry controlsEuropean(79357)ALL(79357)EUR(79357)ALL(79357)Migraine with auraHPOID:0002077Migraine with auraDOID:10024migraine with auraNANANANAMigraineNAMeta-AnalysisANA
7136584363rs1364402TCrs1364402237930254.00E-06NA1.19[1.11-1.28]5,118 European ancestry cases; 74,239 European ancestry controlsEuropean(79357)ALL(79357)EUR(79357)ALL(79357)Migraine with auraHPOID:0002077Migraine with auraDOID:10024migraine with auraNANANANAMigraineNAMeta-AnalysisTCHRM2
820967551rs7015657CGrs7015657237930258.00E-08NA1.15[1.09-1.21]5,118 European ancestry cases; 74,239 European ancestry controlsEuropean(79357)ALL(79357)EUR(79357)ALL(79357)Migraine with auraHPOID:0002077Migraine with auraDOID:10024migraine with auraNANANANAMigrainers7015657-GMeta-AnalysisGNA
824044301rs11777116CTrs11777116237930255.36E-05NA1.19[1.09-1.30]5,118 European ancestry cases; 74,239 European ancestry controlsEuropean(79357)ALL(79357)EUR(79357)ALL(79357)Migraine with auraHPOID:0002077Migraine with auraDOID:10024migraine with auraNANANANAMigrainers11777116-TMeta-AnalysisCNA
856599777rs4738393GArs4738393237930252.03E-04NA1.12[0.84-0.95]5,118 European ancestry cases; 74,239 European ancestry controlsEuropean(79357)ALL(79357)EUR(79357)ALL(79357)Migraine with auraHPOID:0002077Migraine with auraDOID:10024migraine with auraNANANANAMigraineNAMeta-AnalysisGNA
898166913rs1835740TCrs1835740237930251.49E-04NANANA5,118 European ancestry cases; 74,239 European ancestry controlsEuropean(79357)ALL(79357)EUR(79357)ALL(79357)Migraine with auraHPOID:0002077Migraine with auraDOID:10024migraine with auraNANANANAMigraineNAMeta-AnalysisGNA
973094535rs963265TCrs963265237930251.00E-06NA1.12[1.08-1.18]5,118 European ancestry cases; 74,239 European ancestry controlsEuropean(79357)ALL(79357)EUR(79357)ALL(79357)Migraine with auraHPOID:0002077Migraine with auraDOID:10024migraine with auraNANANANAMigraineNAMeta-AnalysisANA
999132044rs10820447CTrs10820447237930256.00E-06NA1.16[1.09-1.23]5,118 European ancestry cases; 74,239 European ancestry controlsEuropean(79357)ALL(79357)EUR(79357)ALL(79357)Migraine with auraHPOID:0002077Migraine with auraDOID:10024migraine with auraNANANANAMigrainers10820447-TMeta-AnalysisCSLC35D2
101471765rs2820651CArs2820651237930254.00E-07NA1.22[1.13-1.31]5,118 European ancestry cases; 74,239 European ancestry controlsEuropean(79357)ALL(79357)EUR(79357)ALL(79357)Migraine with auraHPOID:0002077Migraine with auraDOID:10024migraine with auraNANANANAMigrainers2820651-AMeta-AnalysisGADARB2
106924444rs11816922CArs11816922237930252.06E-04NA1.17[1.08-1.27]5,118 European ancestry cases; 74,239 European ancestry controlsEuropean(79357)ALL(79357)EUR(79357)ALL(79357)Migraine with auraHPOID:0002077Migraine with auraDOID:10024migraine with auraNANANANAMigrainers11816922-AMeta-AnalysisCNA
108091377rs1244181AC,G,Trs1244181237930251.71E-06NA1.15[0.82-0.92]5,118 European ancestry cases; 74,239 European ancestry controlsEuropean(79357)ALL(79357)EUR(79357)ALL(79357)Migraine with auraHPOID:0002077Migraine with auraDOID:10024migraine with auraNANANANAMigraineNAMeta-AnalysisGNA
1029364697rs10826566GArs10826566237930254.00E-06NA1.16[1.09-1.23]5,118 European ancestry cases; 74,239 European ancestry controlsEuropean(79357)ALL(79357)EUR(79357)ALL(79357)Migraine with auraHPOID:0002077Migraine with auraDOID:10024migraine with auraNANANANAMigrainers10826566-AMeta-AnalysisGNA
1030087359rs2986961CTrs2986961237930255.00E-07NA1.14[1.08-1.20]5,118 European ancestry cases; 74,239 European ancestry controlsEuropean(79357)ALL(79357)EUR(79357)ALL(79357)Migraine with auraHPOID:0002077Migraine with auraDOID:10024migraine with auraNANANANAMigrainers2986961-CMeta-AnalysisCNA
1050229638rs2137920TArs2137920237930251.00E-06NA1.15[1.09-1.22]5,118 European ancestry cases; 74,239 European ancestry controlsEuropean(79357)ALL(79357)EUR(79357)ALL(79357)Migraine with auraHPOID:0002077Migraine with auraDOID:10024migraine with auraNANANANAMigrainers2137920-TMeta-AnalysisTVSTM4
1097196978rs2274491TArs2274491237930257.88E-04NA1.09[0.88-0.97]5,118 European ancestry cases; 74,239 European ancestry controlsEuropean(79357)ALL(79357)EUR(79357)ALL(79357)Migraine with auraHPOID:0002077Migraine with auraDOID:10024migraine with auraNANANANAMigraineNAMeta-AnalysisASORBS1
10117973597rs12413355AGrs12413355237930253.00E-06NA1.14[1.08-1.19]5,118 European ancestry cases; 74,239 European ancestry controlsEuropean(79357)ALL(79357)EUR(79357)ALL(79357)Migraine with auraHPOID:0002077Migraine with auraDOID:10024migraine with auraNANANANAMigraineNAMeta-AnalysisGGFRA1
1110673739rs4909945TCrs4909945237930251.22E-04NA1.1[0.87-0.95]5,118 European ancestry cases; 74,239 European ancestry controlsEuropean(79357)ALL(79357)EUR(79357)ALL(79357)Migraine with auraHPOID:0002077Migraine with auraDOID:10024migraine with auraNANANANAMigraineNAMeta-AnalysisCMRVI1
124523456rs10849061CTrs10849061237930252.83E-04NA1.09[0.88-0.96]5,118 European ancestry cases; 74,239 European ancestry controlsEuropean(79357)ALL(79357)EUR(79357)ALL(79357)Migraine with auraHPOID:0002077Migraine with auraDOID:10024migraine with auraNANANANAMigraineNAMeta-AnalysisCNA
1247771429rs2074193TGrs2074193237930255.00E-07NA1.15[1.09-1.21]5,118 European ancestry cases; 74,239 European ancestry controlsEuropean(79357)ALL(79357)EUR(79357)ALL(79357)Migraine with auraHPOID:0002077Migraine with auraDOID:10024migraine with auraNANANANAMigrainers2074193-CMeta-AnalysisGNA
1257527283rs11172113TCrs11172113237930251.11E-05NANANA5,118 European ancestry cases; 74,239 European ancestry controlsEuropean(79357)ALL(79357)EUR(79357)ALL(79357)Migraine with auraHPOID:0002077Migraine with auraDOID:10024migraine with auraNANANANAMigraineNAMeta-AnalysisCLRP1
12101151475rs10778070CArs10778070237930255.88E-04NA1.09[0.88-0.96]5,118 European ancestry cases; 74,239 European ancestry controlsEuropean(79357)ALL(79357)EUR(79357)ALL(79357)Migraine with auraHPOID:0002077Migraine with auraDOID:10024migraine with auraNANANANAMigraineNAMeta-AnalysisCNA
12118272871rs2723279CArs2723279237930259.60E-05NA1.11[0.86-0.95]5,118 European ancestry cases; 74,239 European ancestry controlsEuropean(79357)ALL(79357)EUR(79357)ALL(79357)Migraine with auraHPOID:0002077Migraine with auraDOID:10024migraine with auraNANANANAMigraineNAMeta-AnalysisGKSR2
1335768789rs17051917CTrs17051917237930259.00E-06NA1.19[1.10-1.28]5,118 European ancestry cases; 74,239 European ancestry controlsEuropean(79357)ALL(79357)EUR(79357)ALL(79357)Migraine with auraHPOID:0002077Migraine with auraDOID:10024migraine with auraNANANANAMigraineNAMeta-AnalysisTNBEA
1570634709rs11072158AC,Trs11072158237930253.00E-06NA1.18[1.10-1.27]5,118 European ancestry cases; 74,239 European ancestry controlsEuropean(79357)ALL(79357)EUR(79357)ALL(79357)Migraine with auraHPOID:0002077Migraine with auraDOID:10024migraine with auraNANANANAMigraineNAMeta-AnalysisTNA
1844860264rs9947662GArs9947662237930258.44E-04NA1.09[0.87-0.96]5,118 European ancestry cases; 74,239 European ancestry controlsEuropean(79357)ALL(79357)EUR(79357)ALL(79357)Migraine with auraHPOID:0002077Migraine with auraDOID:10024migraine with auraNANANANAMigraineNAMeta-AnalysisGNA
1846336702rs7227892ATrs7227892237930252.00E-06NA1.14[1.08-1.19]5,118 European ancestry cases; 74,239 European ancestry controlsEuropean(79357)ALL(79357)EUR(79357)ALL(79357)Migraine with auraHPOID:0002077Migraine with auraDOID:10024migraine with auraNANANANAMigraineNAMeta-AnalysisACTIF
1856009604rs12454023CTrs12454023237930258.00E-07NA1.12[1.08-1.18]5,118 European ancestry cases; 74,239 European ancestry controlsEuropean(79357)ALL(79357)EUR(79357)ALL(79357)Migraine with auraHPOID:0002077Migraine with auraDOID:10024migraine with auraNANANANAMigraineNAMeta-AnalysisCNEDD4L
1939174332rs973009GArs973009237930254.00E-06NA1.18[1.10-1.27]5,118 European ancestry cases; 74,239 European ancestry controlsEuropean(79357)ALL(79357)EUR(79357)ALL(79357)Migraine with auraHPOID:0002077Migraine with auraDOID:10024migraine with auraNANANANAMigraineNAMeta-AnalysisAACTN4
2232832874rs2076054CTrs2076054237930258.00E-06NA1.12[1.07-1.18]5,118 European ancestry cases; 74,239 European ancestry controlsEuropean(79357)ALL(79357)EUR(79357)ALL(79357)Migraine with auraHPOID:0002077Migraine with auraDOID:10024migraine with auraNANANANAMigrainers2076054-CMeta-AnalysisTBPIFC
Mapped by lexical matching(Total Items:0)
(Waiting for update.)
Mapped by homologous gene(Total Items:0)
(Waiting for update.)
Chemical(Total Drugs:3)
CUI ChemicalName ChemicalID CasRN DiseaseName DiseaseID DirectEvidence PubMedIDs
C0154723fluoxetineD00547354910-89-3migraine with auraMESH:D020325marker/mechanism8331094
C0154723propranololD011433525-66-6migraine with auraMESH:D020325therapeutic10759905
C0154723tacrolimusD016559109581-93-3migraine with auraMESH:D020325marker/mechanism15836601
FDA approved drug and dosage information(Total Drugs:0)
(Waiting for update.)
FDA labeling changes(Total Drugs:0)
(Waiting for update.)